Neonatal soft tissue sarcomas

Seminars in Fetal and Neonatal Medicine

Volumn 17, Issue 4, 2012, Pages 231-238

  Ferrari, Andrea ^a   Orbach, Daniel ^b   Sultan, Iyad ^c   Casanova, Michela ^a   Bisogno, Gianni ^d  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b INSTITUT CURIE   (France)

^c KING HUSSEIN CANCER CENTER   (Jordan)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

Infantile fibrosarcoma; Infants; Neonatal; Rhabdomyosarcoma; Soft tissue sarcomas; Vascular tumors

Indexed keywords

ALPHA2A INTERFERON; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IMATINIB; IRINOTECAN; METHOTREXATE; NAVELBINE; NONSTEROID ANTIINFLAMMATORY AGENT; TAMOXIFEN; TOPOTECAN; VINBLASTINE; VINCRISTINE;

AGGRESSIVE FIBROMATOSIS; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DESMOID TYPE FIBROMATOSIS; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; EPITHELIOID HEMANGIOENDOTHELIOMA; EXTRARENAL RHABDOID TUMOR; FIBROSARCOMA; HEMANGIOMA; HUMAN; INFANTILE FIBROSARCOMA; KAPOSIFORM HEMANGIOENDOTHELIOMA; KASABACH MERRITT SYNDROME; LOW DRUG DOSE; MALIGNANT SOFT TISSUE TUMOR; METASTASIS; NEONATAL SOFT TISSUE SARCOMA; NEWBORN DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; REVIEW; RHABDOID TUMOR; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR BIOPSY; VASCULAR TUMOR;

DIAGNOSIS, DIFFERENTIAL; FIBROSARCOMA; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; PROGNOSIS; RHABDOID TUMOR; RHABDOMYOSARCOMA; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL ANALYSIS; VASCULAR NEOPLASMS;

EID: 84862239635     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2012.05.003     Document Type: Review

References (48)

1. Ferrari A., Sultan I., Rodriguez-Galindo C., et al. Soft tissue sarcoma across the age spectrum: a population-based study from the Surveillance Epidemiology and End Results database. Pediatr Blood Cancer 2011, 57:943-949.
2. Sultan I., Casanova M., Al Jumaily U., et al. Soft tissue sarcomas in the first year of life. Eur J Cancer 2010, 46:2449-2456.
3. Frieden I.J., Rogers M., Garzon M.C. Conditions masquerading as infantile haemangioma: part 2. Aust J Dermatol 2009, 50:153-170.
4. Yan A.C., Chamlin S.L., Liang M.G., et al. Congenital infantile fibrosarcoma: a masquerader of ulcerated hemangioma. Pediatr Dermatol 2006, 23:330-334.
5. Dubois J., Garel L. Imaging and therapeutic approach of hemangiomas and vascular malformations in the pediatric age group. Pediatr Radiol 1999, 29:879-893.
6. Dubois J., Garel L., David M., Powell J. Vascular soft-tissue tumors in infancy: distinguishing features on Doppler sonography. Am J Roentgenol 2002, 178:1541-1545.
7. Konermann W., Wuisman P., Ellermann A., Gruber G. Ultrasonographically guided needle biopsy of benign and malignant soft tissue and bone tumors. J Ultrasound Med 2000, 19:465-471.
8. Hand J.L., Frieden I.J. Vascular birthmarks of infancy: resolving nosologic confusion. Am J Med Genet 2002, 108:257-264.
9. Coffin C.M., Dehner L.P. Vascular tumors in children and adolescents: a clinicopathological study of 228 tumors in 222 patients. Pathol Annu 1993, 1:97-120.
10. Haggstrom A.N., Drolet B.A., Baselga E., et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006, 118:882-887.
11. Rizzo C., Brightman L., Chapas A., et al. Outcomes of childhood hemangiomas treated with the pulsed dye laser with dynamic cooling: a retrospective chart analysis. Dermatol Surg 2009, 35:1947-1954.
12. Wilson M.W., Hoehn M.E., Haik B.G., et al. Low-dose cyclophosphamide and interferon alfa 2a for the treatment of capillary hemangioma of the orbit. Ophthalmology 2007, 114:1007-1011.
13. Léauté-Labrèze C., Dumas de la Roque E., Hubiche T., et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008, 358:2649-2651.
14. Fahrtash F., McCahon E., Arbuckle S. Successful treatment of kaposiform hemangioendothelioma and tufted angioma with vincristine. J Pediatr Hematol Oncol 2010, 32:506-510.
15. Kumar P., Ladas G.P., Judson I., Nicholson A.G. Epithelioid hemangioendothelioma and other vascular mediastinal tumors: a role for alpha-2a interferon?. Ann Thorac Surg 2003, 76:653.
16. Calabrò L., Di Giacomo A.M., Altomonte M., et al. Primary hepatic epithelioid hemangioendothelioma progressively responsive to interferon-alpha: is there room for novel anti-angiogenetic treatments?. J Exp Clin Cancer Res 2007, 26:145-150.
17. Lyburn I.D., Torreggiani W.C., Harris A.C., et al. Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MR imaging appearances. Am J Roentgenol 2003, 180:1359-1364.
18. Madariaga J.R., Marino I.R., Karavias D.D., et al. Long-term results after liver transplantation for primary hepatic epithelioid hemangioendothelioma. Ann Surg Oncol 1995, 2:483-487.
19. Levine E., Fréneaux P., Schleiermacher G., et al. Risk-adapted therapy for infantile myofibromatosis in children. Pediatr Blood Cancer 2011 Oct 28, [E-pub ahead of print]. 10.1002/pbc.23387.
20. Fetsch J.F., Miettinen M., Laskin W.B., et al. A clinicopathologic study of 45 pediatric soft tissue tumors with an admixture of adipose tissue and fibroblastic elements, and a proposal for classification as lipofibromatosis. Am J Surg Pathol 2000, 24:1491-1500.
21. Speer A.L., Schofield D.E., Wang K.S., et al. Contemporary management of lipoblastoma. J Pediatr Surg 2008, 43:1295-1300.
22. Dômont J., Salas S., Lacroix L., et al. High frequency of beta-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management. Br J Cancer 2010, 102:1032-1036.
23. Meazza C., Bisogno G., Gronchi A., et al. Aggressive fibromatosis in children and adolescents: the Italian experience. Cancer 2010, 116:233-240.
24. Skapek S.X., Ferguson W.S., Granowetter L., et al. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. J Clin Oncol 2007, 25:501-506.
25. Coffin C.M., Jaszcz W., O'Shea P.A., Dehner L.P. So-called congenital-infantile fibrosarcoma: does it exist and what is it?. Pediatr Pathol 1994, 14:133-150.
26. Bourgeois J.M., Knezevich S.R., Mathers J.A., Sorensen P.H. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors. Am J Surg Pathol 2000, 24:937-946.
27. Orbach D., Rey A., Cecchetto G., et al. Infantile fibrosarcoma: management based on the European experience. J Clin Oncol 2010, 28:318-323.
28. Alaggio R., Ninfo V., Rosolen A., Coffin C.M. Primitive myxoid mesenchymal tumor of infancy: a clinicopathologic report of 6 cases. Am J Surg Pathol 2006, 30:388-394.
29. De Giovanni C., Landuzzi L., Nicoletti G., et al. Molecular and cellular biology of rhabdomyosarcoma. Future Oncol 2009, 5:1449-1475.
30. Megarbane H., Doz F., Manach Y., et al. Neonatal rhabdomyosarcoma misdiagnosed as a congenital hemangioma. Pediatr Dermatol 2011, 28:299-301.
31. Yoshino K., Takeuchi M., Nakayama M., Suehara N. Congenital cervical rhabdomyosarcoma arising in one fetus of a twin pregnancy. Fetal Diagn Ther 2005, 20:291-295.
32. Rodriguez-Galindo C., Hill D.A., et al. Neonatal alveolar rhabdomyosarcoma with skin and brain metastases. Cancer 2001, 92:1613-1620.
33. Ragab A.H., Heyn R., Tefft M., et al. Infants younger than one year of age with rhabdomyosarcoma. Cancer 1986, 58:2606-2610.
34. Defachelles A.S., Rey A., Oberlin O., et al. Treatment of nonmetastatic cranial parameningeal rhabdomyosarcoma in children younger than 3 years old: results from International Society of Pediatric Oncology studies MMT 89 and 95. J Clin Oncol 2009, 27:1310-1315.
35. Joshi D., Anderson J.R., Paidas C., et al. Soft Tissue Sarcoma Committee of the Children's Oncology Group. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer 2004, 42:64-73.
36. Ferrari A., Casanova M., Bisogno G., et al. Rhabdomyosarcoma in infants younger than one year old: a report from the Italian Cooperative Group. Cancer 2003, 97:2597-2604.
37. Orbach D., Rey A., Oberlin O., et al. Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee. J Clin Oncol 2005, 23:4363-4371.
38. Koscielniak E., Harms D., Schmidt D., et al. Soft tissue sarcomas in infants younger than 1 year of age: a report of the German Soft Tissue Sarcoma Study Group (CWS-81). Med Pediatr Oncol 1989, 17:105-110.
39. Oberlin O., Rey A., Lyden E., et al. Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 2008, 26:2384-2389.
40. Lobe E., Wiener E.S., Hays D.M., et al. Neonatal rhabdomyosarcoma: the IRS experience. J Pediatr Surg 1994, 29:1167-1170.
41. Dillon P.W., Whalen T.V., Azizkhan R.G., et al. Neonatal soft tissue sarcomas: the influence of pathology on treatment and survival. Children's Cancer Group Surgical Committee. J Pediatr Surg 1995, 30:1038-1041.
42. Biegel J.A., Zhou J.-Y., Rorke L.B., Stenstrom C., Wainwright L.M., Fogelgren B. Germ-line and acquired mutations of INII in atypical teratoid and rhabdoid tumors. Cancer Res 1999, 59:74-79.
43. Bourdeaut F., Fréneaux P., Thuille B., et al. Extra-renal non-cerebral rhabdoid tumours. Pediatr Blood Cancer 2008, 51:363-368.
44. Gururangan S., Bowman L.C., Parham D.M., et al. Primary extracranial rhabdoid tumors. Cancer 1993, 71:2653-2659.
45. Kodet R., Newton W.A., Sachs N., et al. Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the Intergroup Rhabdomyosarcoma Study. Hum Pathol 1991, 22:674-684.
46. Hilden J.M., Watterson J., Longee D.C., et al. Central nervous system atypical teratoid tumor/rhabdoid tumor: response to intensive therapy and review of the literature. J Neurooncol 1998, 40:265-275.
47. Ferrari A., Casanova M. New concepts for the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas. Expert Rev Anticancer Ther 2005, 5:307-318.
48. Ferrari A., Casanova M., Meazza C., et al. Adult-type soft tissue sarcomas in pediatric age: experience at the Istituto Nazionale Tumori in Milan. J Clin Oncol 2005, 23:4021-4030.